ItalyA new international study led by Italian institutions such as Ifom and the Istituto Airc di Oncologia Molecolare in Milan has revealed that breast cancer cells moving in groups become more invasive but also more detectable by the immune system. The research focused on ductal carcinoma in situ, an early form of breast cancer accounting for over 20% of diagnoses. The study identified the protein Rab5a as playing a key role in increasing cellular mobility, which leads to mitochondrial stress and the release of mitochondrial DNA—a signal recognized by the immune system. This discovery could lead to improved immunotherapy strategies and better identification of patients who need treatment, potentially avoiding unnecessary interventions.
Bias read (Center): The article discusses scientific findings related to breast cancer biology and potential therapeutic implications. It presents factual information based on a published study without overt ideological framing or biased language. There is no mention of political figures, policies, or partisan issues.
